MDxHealth SA Files U.S. IPO, to Trade on Nasdaq Under Ticker 'MDXH'

MDxHealth SA (Euronext: MDXH.BR) filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of American Depositary Shares (representing ordinary shares of the Company), which are expected to be listed on the NASDAQ Capital Market in the United States. The number of ADSs to be offered and the timing and price range for the proposed offering have not yet been determined. The public offering is expected to take place after the SEC completes its review process, subject to market and other conditions, including the effectiveness of the abovementioned registration statement.

MDxHealth's ordinary shares are currently listed on Euronext Brussels under the symbol "MDXH". An application has been made to list the ADSs on the NASDAQ Capital Market under the symbol "MDXH".

Piper Sandler is acting as lead book-running manager, Oppenheimer is acting as co-lead book-running manager, BTIG is acting as a lead manager, and KBC Securities USA is acting as a co-manager for the proposed offering.

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• CoStar Group acquires Zonda for $800M, adding new home data
• enVVeno Medical (NVNO) files $100M mixed shelf